The proposed research is based on the view that drugs of abuse have their rewarding impact (and thus their abuse liability) because of their ability to pharmacologically activate brain circuitry involved in natural reward function and natural ingestive behaviors.
The aim of the proposed studies is to advance the understanding of drug abuse by advancing the understanding of brain reward mechanisms and how drugs interact with them. Brain reward systems will be studied using electrophysiological and neuropharmacological techniques, with particular interest in the involvement of dopaminergic and opioid peptides in reward function. The 14 specific aims for the next funding period are: to map the anatomy of brain stimulation reward (BSR) more extensively; to assess more fully the effects of radical dopaminergic destruction on BSR; to further develop paradigms for discriminating drug effects on motor function from those on reward function; to rank-order various neuroleptics relative to their attenuation of BSR; to dissociate task demands from reward effectiveness as a factor in neuroleptic challenge of lever-pressing behavior; to assess the effect of rewarding brain stimulation and reward-associated central morphine injections on striatal and limbic dopamine release; to further quantify the effects of opiates on BSR; to explore the effects of ethanol, barbiturates and benzodiazepines on BSR using new and more sensitive paradigms; to determine the effects of intracranial opiate receptor blockade on BSR; to determine the effects of opiate receptor blockade on reward facilitation by ethanol, barbiturates and benzodiazepines (should these drugs prove to reliably facilitate BSR); to determine the effects of neuroleptics on food reward as reflected in a free-feeding task; to determine the effects of intracranial neuroleptics on food reward; to determine the effect of intracranial morphine on food reward and feeding behavior; to map the substrate for turning behavior elicited by central morphine injections. It is hoped that these studies will advance the understanding of the anatomical circuitry at which drugs of abuse have their interface with the mechanisms of behavioral control by the brain.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA001720-09
Application #
3206996
Study Section
Drug Abuse Clinical and Behavioral Research Review Committee (DACB)
Project Start
1977-04-01
Project End
1986-04-30
Budget Start
1985-05-01
Budget End
1986-04-30
Support Year
9
Fiscal Year
1985
Total Cost
Indirect Cost
Name
Concordia University
Department
Type
DUNS #
City
Montreal
State
PQ
Country
Canada
Zip Code
H3G1M8
You, Z B; Chen, Y Q; Wise, R A (2001) Dopamine and glutamate release in the nucleus accumbens and ventral tegmental area of rat following lateral hypothalamic self-stimulation. Neuroscience 107:629-39
Kiyatkin, E A; Gratton, A (1994) Electrochemical monitoring of extracellular dopamine in nucleus accumbens of rats lever-pressing for food. Brain Res 652:225-34
Gratton, A; Wise, R A (1994) Drug- and behavior-associated changes in dopamine-related electrochemical signals during intravenous cocaine self-administration in rats. J Neurosci 14:4130-46
Devine, D P; Leone, P; Wise, R A (1993) Mesolimbic dopamine neurotransmission is increased by administration of mu-opioid receptor antagonists. Eur J Pharmacol 243:55-64
Carlezon Jr, W A; Wise, R A (1993) Morphine-induced potentiation of brain stimulation reward is enhanced by MK-801. Brain Res 620:339-42
Hoffman, D C; Wise, R A (1993) Lack of cross-sensitization between the locomotor-activating effects of bromocriptine and those of cocaine or heroin. Psychopharmacology (Berl) 110:402-8
Wolske, M; Rompre, P P; Wise, R A et al. (1993) Activation of single neurons in the rat nucleus accumbens during self-stimulation of the ventral tegmental area. J Neurosci 13:1-12
Devine, D P; Leone, P; Pocock, D et al. (1993) Differential involvement of ventral tegmental mu, delta and kappa opioid receptors in modulation of basal mesolimbic dopamine release: in vivo microdialysis studies. J Pharmacol Exp Ther 266:1236-46
Hoffman, D C; West, T E; Wise, R A (1991) Ventral pallidal microinjections of receptor-selective opioid agonists produce differential effects on circling and locomotor activity in rats. Brain Res 550:205-12
Gerber, G J; Wise, R A (1989) Pharmacological regulation of intravenous cocaine and heroin self-administration in rats: a variable dose paradigm. Pharmacol Biochem Behav 32:527-31

Showing the most recent 10 out of 25 publications